First-pass extracted concept

engineered cell-based sensing platforms

Candidate: concept label1 source documents6 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Engineered cell-based sensing platforms use modified cells as the sensing element in optogenetic biosensors. The review emphasizes them as a central platform type for diagnostics and biosensor development.

Source 1DOI PubMed

Engineered cell-based sensing platforms use modified cells as the sensing element in optogenetic biosensors. In this review they are the main application context for the discussed toolbox and biomaterials.

Source 1DOI PubMed

Resources required

The abstract supports the need for engineered cells and an optogenetic toolbox, along with unified analytic platforms.

Source 1DOI PubMed

These platforms require engineered cells and supporting analytical platforms. The abstract also implies dependence on light-responsive biomaterials and optogenetic components.

Source 1DOI PubMed

What problem it solves

These platforms are presented as a way to improve speed, sensitivity, and standardization in cellular biosensing.

Source 1DOI PubMed

They provide a route to real-time cellular diagnostics and sensitive detection of bioactive or toxic analytes. The review presents them as a central biosensing format.

Source 1DOI PubMed

What it does not solve

The abstract does not establish which engineered-cell format is optimal across analytes or tissues. It also does not provide detailed manufacturing or deployment guidance.

Source 1DOI PubMed

Alternatives

The abstract implicitly contrasts them with classical cellular sensors that are slower and less sensitive.

Source 1DOI PubMed

Evidence Snippets

particular focus on the use of engineered cells for cell-based sensing platforms

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2021MaterialsDOI PubMed

1 evidence snippet 6 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1comparative advantagesupports2021Source 1DOI PubMed

Modified optogenetic cell-based biosensors are described as enabling significantly faster detection, on the order of minutes instead of hours, compared with classical cellular sensors.

Claim 2comparative advantagesupports2021Source 1DOI PubMed

Modified optogenetic cell-based biosensors offer faster detection than classical cellular sensors.

Claim 3performance advantagesupports2021Source 1DOI PubMed

Modified optogenetic cell-based biosensors provide higher sensitivity for detecting low concentrations of bioactive or toxic analytes than classical cellular sensors.

Claim 4review scopesupports2021Source 1DOI PubMed

The review focuses on engineered-cell sensing platforms, enabling biomaterials, and an optogenetic toolbox spanning actuators, reporters, and multifunctional opto-chemogenetic tools for real-time cellular diagnostics and biosensor development.

Claim 5review scopesupports2021Source 1DOI PubMed

This paper reviews enabling biomaterials and novel biosensing concepts involving optogenetics, with emphasis on engineered cell-based sensing platforms and toolboxes for real-time cellular diagnostics and biosensor development.

Claim 6sensitivity advantagesupports2021Source 1DOI PubMed

Modified optogenetic cell-based biosensors are described as having higher sensitivity for detecting low concentrations of bioactive or toxic analytes, including below threshold concentrations for classical cellular sensors.